: PRTA

Prothena Corporation PLC (NASDAQ: PRTA)

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on the discovery, development, and commercialization of novel immunotherapies for the treatment of diseases in the neuroscience and orphan categories. Take a look at the 1-year chart of Prothena (NASDAQ: PRTA) below with the added notations: Over the course of the past four months, PRTA has… Continue Reading »